A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam – FutureNeuro

Skip to content

Search our Website

My Moving Brain Community Connect Event

Home•Our Research•Publications•A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam

Thematic Area:

Diagnostics

Disease Area:

Epilepsy Psychosis

Research Focus:

Biomarkers Genomics

Collaborators:

Academic Clinical